Company / EPS (Diluted)
Annexon, Inc. EPS (Diluted) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.01
FY2024
5-year range
-$3.40 / -$1.01
FY2021-FY2024
Trend
+42.9%
vs FY2023
Sector context
#81 of 204
Health Care
What the data says
At $-1.01, Annexon, Inc.'s eps (diluted) ranks #81 of 204 in the Health Care sector. EPS (Diluted) has increased for 3 consecutive years, from $-3.40 in FY2021 to $-1.01 in FY2024.
Based on SEC 10-K filings.
-1.01 in FY2024.
Improved from $-2.60 to $-1.01 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 204 in Health CareTop 40% of 204This company -$1.01 Sector average -$1.03
▼
+2.1% above sector average
Key checks
Key Insights
- Annexon, Inc.'s eps (diluted) has grown for 3 consecutive years.
- In FY2024, eps (diluted) increased 42.9% year-over-year.
- Ranks #81 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.01 | +42.9% |
| FY2023 | -$1.77 | +31.9% |
| FY2022 | -$2.60 | +23.5% |
| FY2021 | -$3.40 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026